CVR: 40638350
DKK 1,095,622
Gross profit
Net result: DKK 2,364,576
Ginnerup Capital ApS, A. Kazemi ApS
CVR · view ownership and management
Owner registered: Ginnerup Capital ApS
CVR · 17/05/2021
View the full event history
Metaceutic ApS is a Danish company of the type Anpartsselskab based in Skovlunde, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali Kazemi Seresht. The company is owned by Ginnerup Capital ApS and A. Kazemi ApS. In 2025, the company reported a gross profit of DKK 1,095,622 and a net result of DKK 2,364,576 compared with DKK -1,318,986 the year before. Equity in the 2025 report amounted to DKK 276,791.
Source: annual report 2025, Danish Business Authority
Metaceutic ApS has shown a significant turnaround in its financial health, achieving a gross profit of 1,095,622 DKK and a profit of 2,364,576 DKK in 2025, following several years of losses. Prior to this, the company faced declining performance with negative gross profits and increasing losses, peaking at -4,185,532 DKK in 2021. The equity position has fluctuated, moving from positive to negative values, but improved to 276,791 DKK in 2025, indicating a recovery. Despite the lack of disclosed revenue figures, the recent profitability suggests a strengthening position within the research and experimental development sector, although concerns about past equity deficits and operational sustainability remain.
AI-generated summary · Generated 15/08/2026
Selskabets formål er anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.1 mio. | 2.4 mio. | 2.4 mio. | 277 t. | 2 | |
| 202401/01/2024 – 31/12/2024 | -48 t. | -1.3 mio. | 954 t. | -2.1 mio. | 1 | |
| 202301/01/2023 – 31/12/2023 | -1.2 mio. | -2 mio. | 1.1 mio. | -769 t. | 1 | |
| 202201/01/2022 – 31/12/2022 | -987 t. | -1.8 mio. | 1.8 mio. | 1.3 mio. | 2 | |
| 202101/01/2021 – 31/12/2021 | -2.2 mio. | -4.2 mio. | 2.5 mio. | 2.1 mio. | 4 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorMetaceutic ApS was founded on 4 July 2019.
Metaceutic ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Metaceutic ApS is owned by Ginnerup Capital ApS and A. Kazemi ApS.
In 2025, Metaceutic ApS reported a gross profit of DKK 1,095,622.
The management of Metaceutic ApS consists of Ali Kazemi Seresht.
Metaceutic ApS is located at Mileparken 22 2., 2740 Skovlunde.
Claim this page to add your logo and social links. Free to get started.
Metaceutic ApS has published its annual report for 2025. Gross profit came to DKK 1,095,622, and the net result was DKK 2,364,576.
Address changed to Mileparken 22 2. 22, 2, 2740 Skovlunde (January 28, 2026).
Metaceutic ApS has published its annual report for 2024. Gross profit came to DKK -48,469, and the net result was DKK -1,318,986.
Metaceutic ApS has published its annual report for 2023. Gross profit came to DKK -1,182,542, and the net result was DKK -2,036,587.
As of June 19, 2024, Jan Greve has left the board of directors of Metaceutic ApS.
As of June 19, 2024, Kim Erik Ginnerup has left the board of directors of Metaceutic ApS.
As of June 19, 2024, Ali Kazemi Seresht has left the board of directors of Metaceutic ApS.
Metaceutic ApS has published its annual report for 2022. Gross profit came to DKK -987,282, and the net result was DKK -1,801,730.
As of June 22, 2023, Jakob Saabye-Brøndum has left the board of directors of Metaceutic ApS.
Metaceutic ApS has published its annual report for 2021. Gross profit came to DKK -2,188,780, and the net result was DKK -4,185,532.
Metaceutic ApS has published its interim report for the period July 4, 2019 – December 31, 2020.
As of May 17, 2021, Ginnerup Capital ApS is registered as an owner of Metaceutic ApS with an ownership share of 5%.
As of May 17, 2021, A. Kazemi ApS is registered as an owner of Metaceutic ApS with an ownership share of 66%.
As of June 18, 2020, Jan Greve has joined the board of directors of Metaceutic ApS.
As of June 18, 2020, Kim Erik Ginnerup has joined the board of directors of Metaceutic ApS.
As of June 18, 2020, Ali Kazemi Seresht has joined the board of directors of Metaceutic ApS.
As of June 18, 2020, Maria Maibøl Jakobsen has left the board of directors of Metaceutic ApS.
As of June 17, 2020, Ali Kazemi Seresht has left the board of directors of Metaceutic ApS.
As of July 4, 2019, Jakob Saabye-Brøndum has joined the board of directors of Metaceutic ApS.
As of July 4, 2019, Ali Kazemi Seresht has joined the board of directors of Metaceutic ApS.
As of July 4, 2019, Maria Maibøl Jakobsen has joined the board of directors of Metaceutic ApS.
As of July 4, 2019, Ali Kazemi Seresht is registered as director of Metaceutic ApS.
Metaceutic ApS was founded on July 4, 2019.
Companies in the same industry and area
CVR 44861429
CVR 30799968
CVR 40848460
CVR 46356292
CVR 39871033
